Institutional Ownership Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 44.4 Million shares, which have been reported (via 13F filing form) to have a value of $12.4 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Boothbay Fund Management, LLC
New York, NY |
May 15, 2024 Q1 2024 |
232,670
shares
|
$65,147
0.03% of portfolio
|
Q1 2024
Reduced 6.91%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
190,986
shares
|
$53,476
0.0% of portfolio
|
Q1 2024
Added 69.56%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
183,743
shares
|
$51,448
0.0% of portfolio
|
Q1 2024
Added 38.56%
|
|
Acuta Capital Partners, LLC
Belmont, CA |
May 15, 2024 Q1 2024 |
173,320
shares
|
$48,529
0.88% of portfolio
|
Q1 2024
New holding
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
159,597
shares
|
$44,687
0.0% of portfolio
|
Q1 2024
Added 10.31%
|
|
Jane Street Group, LLC
New York, NY |
May 15, 2024 Q1 2024 |
157,703
shares
|
$44,156
0.0% of portfolio
|
Q1 2024
Added 101.53%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
151,919
shares
|
$42,537
0.0% of portfolio
|
Q1 2024
Added 37.11%
|
|
Superstring Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
145,284
shares
|
$40,679
0.6% of portfolio
|
Q1 2024
New holding
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
143,900
shares
|
$40,292
0.0% of portfolio
|
Q1 2024
Added 183.83%
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
131,902
shares
|
$36,932
0.0% of portfolio
|
Q1 2024
Added 137.88%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
126,180
shares
|
$35,330
0.0% of portfolio
|
Q1 2024
Added 15.57%
|
|
Clearline Capital LP
New York, NY |
May 15, 2024 Q1 2024 |
119,128
shares
|
$33,355
0.04% of portfolio
|
Q2 2022
Reduced 0.66%
|
|
Citigroup Inc
|
May 10, 2024 Q1 2024 |
118,875
shares
|
$33,285
0.0% of portfolio
|
Q1 2024
Reduced 4.47%
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
109,405
shares
|
$30,633
0.0% of portfolio
|
Q1 2024
Added 229.83%
|
|
Hrt Financial LP
New York, NY |
May 13, 2024 Q1 2024 |
98,525
shares
|
$27,587
0.0% of portfolio
|
Q1 2024
New holding
|
|
Man Group PLC
London, X0 |
May 15, 2024 Q1 2024 |
90,283
shares
|
$25,279
0.0% of portfolio
|
Q1 2024
Added 137.57%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2024 Q1 2024 |
86,800
shares
|
$24,304
0.01% of portfolio
|
Q1 2024
Reduced 38.79%
|
|
Marathon Trading Investment Management LLC
Radnor, PA |
May 10, 2024 Q1 2024 |
67,010
shares
|
$18,762
0.18% of portfolio
|
Q1 2024
New holding
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
64,392
shares
|
$18,029
0.0% of portfolio
|
Q1 2024
New holding
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
60,495
shares
|
$16,938
0.0% of portfolio
|
Q1 2024
Reduced 1.71%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
50,900
shares
|
$14,252
0.0% of portfolio
|
Q1 2024
Added 15.95%
|
|
Cambridge Investment Research Advisors, Inc.
|
Apr 24, 2024 Q1 2024 |
41,563
shares
|
$11,637
0.0% of portfolio
|
Q1 2024
New holding
|
|
Barclays PLC
London, X0 |
May 15, 2024 Q1 2024 |
32,817
shares
|
$9,188
0.0% of portfolio
|
Q4 2023
New holding
|
|
Exodus Point Capital Management, LP
New York, NY |
May 14, 2024 Q1 2024 |
32,118
shares
|
$8,993
0.0% of portfolio
|
Q1 2024
New holding
|
|
Letko, Brosseau & Associates Inc
Montreal, A8 |
May 08, 2024 Q1 2024 |
31,900
shares
|
$8,932
0.0% of portfolio
|
Q2 2023
New holding
|